These injuries have been documented in patients using both FDA-approved diabetes treatments and medications prescribed for weight loss
The debate around GLP-1 coverage is a prime example of the balancing act benefits leaders face as they navigate skyrocketing demand, affordability concerns, and uncertainty around long-term patient outcomes. Just last week, Cigna confirmed it was no longer covering GLP-1 weight loss drugs for its own employees effective July 1
DeL, HY, KT, MB and JR added critical intellectual content to the manuscript and can be considered experts on the topic
The dosage ultimately depends on your current condition and how well you are responding to the medication
GLP-1R activation has been suggested to enhance the ability of RPE cells to counteract inflammation and oxidative stress, as RPE cells exposed to TNF-alpha and high glucose show enhanced survival characteristics following treatment with exenatide [83, 84]